Home » Newsletters » BioWorld Asia

BioWorld Asia

May 12, 1999

View Archived Issues

Hard Times Force Amrad To Restructure, Refocus

OGS Unloads Biochemicals, Pushes Proteomics Research

Thymus Atrophy In Clone Shows Long-Term Effects Of Using Adult Somatic Cells

Foresight Study Recommends: Commit IEP70M To Biotech

New Tech-Transfer Firm Focused On Cancer Work

Polymasc, Onyx Sign Deal For Virus Coating Product

York University Spin-Out Funded For DEP Efforts

Venture Group, Government Seeking CEO For New Firm

Genset, Johns Hopkins Enter Schizophrenia Research Deal

Berlin Start-Up Focused On Epigenetics Research

Fidelity Investments Adds C$6M To Theratechnologies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...